×
Home Current Archive Editorial board
News Contact
Case report

Wernicke encephalopathy: Late-stage symptoms

By
Aleksandra Lučić-Prokin Orcid logo ,
Aleksandra Lučić-Prokin

Klinički centar Vojvodine , Novi Sad , Serbia

Vladimir Galić Orcid logo ,
Vladimir Galić

Klinički centar Vojvodine , Novi Sad , Serbia

Timea Kokai-Zekić ,
Timea Kokai-Zekić

Klinički centar Vojvodine , Novi Sad , Serbia

Vedran Žigić
Vedran Žigić

Klinički centar Vojvodine , Novi Sad , Serbia

Abstract

Wernicke encephalopathy is a rare acute/subacute neurological disorder, commonly caused by prolonged thiamine deficiency in patients who chronically consume alcohol. According to the Caine classification criteria, the clinical diagnosis of this encephalopathy involves at least two of the following four signs: nutritional deficiency, oculomotor dysfunction, ataxia, and changes in the mental status. This case report highlights rare clinical signs in the late stage of the disease, as well as the consequences of possible local hypoperfusion of the brainstem in the form of an ischemic vascular event. A 39-year-old female patient (previously treated at a regional general hospital) was admitted to the Department of Emergency Neurology at the University Clinical Center of Vojvodina with a history of a series of epileptic seizures, altered consciousness, oculomotor signs, opisthotonus, and cognitive dysfunction, following years of alcohol consumption and nutritional deficiency. The diagnosis was confirmed by typical neuroimaging findings and specific laboratory tests. Hypertonia with subsequent opisthotonus was one of the clinical manifestations in our patient, while the occurrence of an ischemic stroke was an unexpected event. Empirical administration of high-dose thiamine, along with additional supportive intensive therapy, did not yield satisfactory outcomes. Wernicke encephalopathy represents a clinical diagnosis based on physical and neurological examination, with neuroimaging. Early recognition of both common and unusual symptoms, particularly in the late stage of the disease, could potentially reduce morbidity and mortality. It is essential to administer thiamine before glucose infusion to all patients with an undetermined cause of altered consciousness.

References

1.
Zhang SX, Weilersbacher GS, Henderson SW, Corso T, Olney JW, Langlais PJ. Excitotoxic Cytopathology, Progression, and Reversibility of Thiamine Deficiency-induced Diencephalic Lesions. Journal of Neuropathology and Experimental Neurology. 1995;54(2):255–67.
2.
Sullivan EV, Pfefferbaum A. Magnetic Resonance Relaxometry Reveals Central Pontine Abnormalities in Clinically Asymptomatic Alcoholic Men. Alcoholism: Clinical and Experimental Research. 2001;25(8):1206–12.
3.
Oka M, Terae S, Kobayashi R, Kudoh K, Chu BC, Kaneko K, et al. Diffusion-weighted MR findings in a reversible case of acute Wernicke encephalopathy. Acta Neurologica Scandinavica. 2001;104(3):178–81.
4.
Karhune PJ, Erkinjuntti T, Laippala P. Moderate alcohol consumption and loss of cerebellar Prikinje cells. BMJ. 1994;308(6945):1663–7.
5.
Harper C, Butterworth R. Nutritional and metabolic disorders. In: Greenfield’s Neuropatholog. 1997. p. 601–52.
6.
Sinha S, Kataria A, Kolla BP, Thusius N, Loukianova LL. Wernicke Encephalopathy—Clinical Pearls. Mayo Clinic Proceedings. 2019;94(6):1065–72.
7.
Sullivan EV, Pfefferbaum A. Neuroimaging of the Wernicke-Korsakoff Syndrome. Alcohol and Alcoholism. 44(2):155–65.
8.
Vetreno RP, Ramos RL, Anzalone S, Savage LM. Brain and behavioral pathology in an animal model of Wernicke’s encephalopathy and Wernicke–Korsakoff Syndrome. Brain Research. 2012;1436:178–92.
9.
Takakusaki K, Chiba R, Nozu T, Okumura T. Brainstem control of locomotion and muscle tone with special reference to the role of the mesopontine tegmentum and medullary reticulospinal systems. Journal of Neural Transmission. 2016;123(7):695–729.
10.
Galvin R, Bråthen G, Ivashynka A, Hillbom M, Tanasescu R, Leone MA. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. European Journal of Neurology. 2010;17(12):1408–18.
11.
Schabelman E, Kuo D. Glucose before Thiamine for Wernicke Encephalopathy: A Literature Review. The Journal of Emergency Medicine. 2012;42(4):488–94.
12.
Murata T, Fujito T, Kimura H, Omori M, Itoh H, Wada Y. Serial MRI and 1H-MRS of Wernicke’s encephalopathy: report of a case with remarkable cerebellar lesions on MRI. Psychiatry Research: Neuroimaging. 2001;108(1):49–55.
13.
Koguchi K, Nakatsuji Y, Abe K, Sakoda S. Wernicke’s encephalopathy after glucose infusion. Neurology. 2004;62(3):512–512.
14.
Caine D, Halliday GM, Kril JJ, Harper CG. Operational criteria for the classification of chronic alcoholics: identification of Wernicke’s encephalopathy. Journal of Neurology, Neurosurgery & Psychiatry. 1997;62(1):51–60.
15.
Zuccoli G, Santa Cruz D, Bertolini M, Rovira A, Gallucci M, Carollo C, et al. MR Imaging Findings in 56 Patients with Wernicke Encephalopathy: Nonalcoholics May Differ from Alcoholics. American Journal of Neuroradiology. 2009;30(1):171–6.
16.
Sechi G, Serra A. Wernicke’s encephalopathy: new clinical settings and recent advances in diagnosis and management. The Lancet Neurology. 2007;6(5):442–55.
17.
Donnino MW, Vega J, Miller J, Walsh M. Myths and Misconceptions of Wernicke’s Encephalopathy: What Every Emergency Physician Should Know. Annals of Emergency Medicine. 2007;50(6):715–21.

Citation

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.